Align Technology Cash Flow Statement
ALGN / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 15 fiscal years. All figures from audited SEC 10-K filings.
Align Technology generated $593M in operating cash flow and $491M in free cash flow in FY2025. Free cash flow margin was 12.2% of revenue.
Based on SEC 10-K filings.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $410.4M | $421.4M | $445.1M | $361.6M | $772.0M | $1.8B | $442.8M | $400.2M | $231.4M | $189.7M | $144.0M | $145.8M | $64.3M | $58.7M | $66.7M |
| Depreciation & Amortization | $237.4M | $145.0M | $142.4M | $125.8M | $108.7M | $93.5M | $79.0M | $54.7M | $37.7M | $24.0M | $18.0M | $17.9M | $16.8M | $17.8M | $12.1M |
| Operating Cash Flow | $593.2M | $738.2M | $785.8M | $568.7M | $1.2B | $662.2M | $747.3M | $554.7M | $438.5M | $247.7M | $238.0M | $226.9M | $186.0M | $133.8M | $130.5M |
| Capital Expenditures | $102.4M | $115.6M | $177.7M | $291.9M | $401.1M | $154.9M | $149.7M | $223.3M | $195.7M | $70.6M | $53.5M | $24.1M | $19.4M | $38.3M | $30.4M |
| Free Cash Flow | $490.8M | $622.7M | $608.1M | $276.8M | $771.4M | $507.3M | $597.6M | $331.4M | $242.8M | $177.1M | $184.5M | $202.8M | $166.6M | $95.4M | $100.1M |
| Share Buybacks | $465.9M | $352.9M | $592.4M | $435.0M | $375.0M | $0 | $400.0M | $300.0M | $103.8M | $96.2M | $101.8M | $98.2M | $95.1M | $47.2M | $7.8M |
| FCF Margin | 12.2% | 15.6% | 15.7% | 7.4% | 19.5% | 20.5% | 24.8% | 16.9% | 16.5% | 16.4% | 21.8% | 26.6% | 25.2% | 17.0% | 20.9% |